Anti COVID-19 Hyperimmune Intravenous Immunoglobulin (C-IVIG)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti COVID-19 Hyperimmune Intravenous Immunoglobulin (C-IVIG), covering 2022-10-17 to 2022-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Anti COVID 19 Hyperimmune Intravenous Immunoglobulin (C-IVIG) Therapy for Severe COVID-19 Patients [Phase 2, Phase 3]